XML 49 R32.htm IDEA: XBRL DOCUMENT v3.25.3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Oct. 03, 2025

Accounting Policies [Abstract]

Schedule of Prior Period Revisions

The following tables provide a reconciliation of the revisions for the previously reported Consolidated Statements of Operations, Consolidated Statements of Comprehensive (Loss) Income, Consolidated Statements of Stockholders' Equity, and Consolidated Statements of Cash Flows as of the fiscal years ended September 27, 2024 and September 29, 2023 and the revisions for the previously reported Consolidated Balance Sheets as of the fiscal year ended September 27, 2024.

CONSOLIDATED STATEMENTS OF OPERATIONS

			Fiscal Years
			2024																		2023
(In millions, except per share amounts)			As Previously Reported						Revision						As Revised						As Previously Reported						Revision						As Revised
Income tax expense (benefit)			$	52.2					$	1.1					$	53.3					$	(17.4)					$	0.8					$	(16.6)
Net (loss) income			(47.2)						(1.1)						(48.3)						48.7						(0.8)						47.9
Net (loss) income attributable to Varex			(47.7)						(1.1)						(48.8)						48.2						(0.8)						47.4
Net (loss) income per common share attributable to Varex
Basic			$	(1.17)					$	(0.03)					$	(1.20)					$	1.20					$	(0.02)					$	1.18
Diluted			$	(1.17)					$	(0.03)					$	(1.20)					$	1.08					$	(0.01)					$	1.07

CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

			Fiscal Years
			2024																		2023
(In millions)			As Previously Reported						Revision						As Revised						As Previously Reported						Revision						As Revised
Net (loss) income			$	(47.2)					$	(1.1)					$	(48.3)					$	48.7					$	(0.8)					$	47.9
Total comprehensive (loss) income			(48.9)						(1.1)						(50.0)						47.4						(0.8)						46.6
Comprehensive (loss) income attributable to Varex			(49.4)						(1.1)						(50.5)						46.9						(0.8)						46.1

CONSOLIDATED BALANCE SHEETS

						September 27, 2024
(In millions)						As Previously Reported						Revision						As Revised
Deferred tax assets						$	4.7					$	(3.4)					$	1.3
Total assets						1,217.0						(3.4)						1,213.6
Deferred tax liabilities						1.4						2.6						4.0
Total liabilities						667.8						2.6						670.4
Retained earnings						70.4						(6.0)						64.4
Total Varex stockholders' equity						535.1						(6.0)						529.1
Total stockholders' equity						549.2						(6.0)						543.2
Total liabilities and stockholders' equity						1,217.0						(3.4)						1,213.6

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(In millions)			Retained Earnings						Total Varex Equity						Total Stockholders' Equity
As Previously Reported
For the Year Ended September 29, 2023
Balance at September 30, 2022			$	63.8					$	533.4					$	546.7
Net income			48.2						48.2						48.7
Balance at September 29, 2023			$	118.1					$	567.7					$	581.0
Revision
For the Year Ended September 29, 2023
Balance at September 30, 2022			$	(4.1)					$	(4.1)					$	(4.1)
Net loss			(0.8)						(0.8)						(0.8)
Balance at September 29, 2023			$	(4.9)					$	(4.9)					$	(4.9)
As Revised
For the Year Ended September 29, 2023
Balance at September 30, 2022			$	59.7					$	529.3					$	542.6
Net income			47.4						47.4						47.9
Balance at September 29, 2023			$	113.2					$	562.8					$	576.1
(In millions)			Retained Earnings						Total Varex Equity						Total Stockholders' Equity
As Previously Reported
For the Year Ended September 27, 2024
Balance at September 29, 2023			$	118.1					$	567.7					$	581.0
Net loss			(47.7)						(47.7)						(47.2)
Balance at September 27, 2024			$	70.4					$	535.1					$	549.2
Revision
For the Year Ended September 27, 2024
Balance at September 29, 2023			$	(4.9)					$	(4.9)					$	(4.9)
Net loss			(1.1)						(1.1)						(1.1)
Balance at September 27, 2024			$	(6.0)					$	(6.0)					$	(6.0)
As Revised
For the Year Ended September 27, 2024
Balance at September 29, 2023			$	113.2					$	562.8					$	576.1
Net loss			(48.8)						(48.8)						(48.3)
Balance at September 27, 2024			$	64.4					$	529.1					$	543.2

CONSOLIDATED STATEMENTS OF CASH FLOWS

			Fiscal Years
			2024																		2023
(In millions)			As Previously Reported						Revision						As Revised						As Previously Reported						Revision						As Revised
Cash flows from operating activities:
Net (loss) income			$	(47.2)					$	(1.1)					$	(48.3)					$	48.7					$	(0.8)					$	47.9
Deferred taxes			37.0						1.1						38.1						(39.5)						0.8						(38.7)

    These revisions had no impact on gross profit, operating expenses, or operating income in any of the fiscal periods.

Schedule of Cash and Cash Equivalents

Cash and cash equivalents and restricted cash as reported within the Consolidated Statements of Cash Flows consisted of the following:

			October 3, 2025												September 27, 2024
(In millions)			Beginning of Period						End of Period						Beginning of Period						End of Period
Cash and cash equivalents			$	168.7					$	145.0					$	152.6					$	168.7
Restricted cash			1.7						2.1						1.4						1.7
Total as presented in the Consolidated Statements of Cash Flows			$	170.4					$	147.1					$	154.0					$	170.4

Schedule of Restrictions on Cash and Cash Equivalents

Cash and cash equivalents and restricted cash as reported within the Consolidated Statements of Cash Flows consisted of the following:

			October 3, 2025												September 27, 2024
(In millions)			Beginning of Period						End of Period						Beginning of Period						End of Period
Cash and cash equivalents			$	168.7					$	145.0					$	152.6					$	168.7
Restricted cash			1.7						2.1						1.4						1.7
Total as presented in the Consolidated Statements of Cash Flows			$	170.4					$	147.1					$	154.0					$	170.4

Schedule of Customers with a Significant Portion of Revenue

During the periods presented, one of the Company's customers accounted for a significant portion of revenues, as set forth below:

			Fiscal Years
			2025						2024						2023
Canon Medical Systems Corporation			18.0		%				17.6		%				16.5		%

Schedule of Inventory, Current

The following table summarizes the Company’s inventories, net:

(In millions)			October 3, 2025						September 27, 2024
Raw materials and parts			$	228.1					$	214.5
Work-in-process			31.3						16.2
Finished goods			40.0						34.1
Total inventories, net			$	299.4					$	264.8

Property, Plant and Equipment

The following table summarizes the Company’s property, plant, and equipment, net:

(In millions)			October 3, 2025						September 27, 2024
Land			$	8.6					$	8.6
Buildings and leasehold improvements			166.3						165.5
Machinery and equipment			217.0						206.5
Construction in progress			36.9						25.0
Gross property, plant, and equipment			$	428.8					$	405.6
Less: Accumulated depreciation and amortization			(271.0)						(252.2)
Total property, plant, and equipment, net			$	157.8					$	153.4

Supplier Finance Program

The following table presents the change in the direct supplier financing obligation:

(In millions)			October 3, 2025						September 27, 2024
Confirmed obligations outstanding at the beginning of the period			$	2.6					$	4.2
Invoices confirmed during the period			27.9						31.3
Confirmed invoices paid during the period			(27.6)						(32.9)
Confirmed obligations outstanding at the end of the period			$	2.9					$	2.6

Schedule of Product Warranty Liability

The following table reflects the changes in the Company’s accrued product warranty:

(In millions)			October 3, 2025						September 27, 2024
Accrued product warranty, at beginning of period			$	10.8					$	7.7
New accruals charged to cost of revenues			13.0						21.0
Product warranty expenditures			(15.3)						(17.9)
Accrued product warranty, at end of period			$	8.5					$	10.8

X

- References

No definition available.

+ Details

Name:	us-gaap_AccountingPoliciesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-SubTopic 10
-Topic 360
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-1

+ Details

Name:	us-gaap_PropertyPlantAndEquipmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the components of cash and cash equivalents.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-7

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-8

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-9

+ Details

Name:	us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-SubTopic 10
-Topic 210
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483489/210-10-50-1

+ Details

Name:	us-gaap_ScheduleOfInventoryCurrentTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482425/460-10-50-8

+ Details

Name:	us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 944
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(1)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482913/230-10-50-8

+ Details

Name:	us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-18

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 20
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-20

+ Details

Name:	us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of supplier finance program.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 405
-SubTopic 50
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479468/405-50-50-3

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 405
-SubTopic 50
-Name Accounting Standards Codification
-Section 55
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477128/405-50-55-5

+ Details

Name:	us-gaap_SupplierFinanceProgramTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration